| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/02/2002 | EP1165796A2 Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines |
| 01/02/2002 | EP1165795A2 Streptococcus pneumoniae antigens |
| 01/02/2002 | EP1165794A1 Pathogen inducible promoter |
| 01/02/2002 | EP1165790A1 Protease activated receptor 2 variants |
| 01/02/2002 | EP1165789A2 Vesicle associated proteins |
| 01/02/2002 | EP1165788A2 Molecules of the immune system |
| 01/02/2002 | EP1165787A2 Isolated dna encoding cullin regulators roc1 and roc2, isolated proteins encoded by the same, and methods utilizing the same |
| 01/02/2002 | EP1165785A1 48 human secreted proteins |
| 01/02/2002 | EP1165784A2 Nucleic acids including open reading frames encoding polypeptides; "orfx" |
| 01/02/2002 | EP1165781A2 Protease resistant flint analogs |
| 01/02/2002 | EP1165780A2 Flint polypeptide analogs |
| 01/02/2002 | EP1165778A2 Casb618 polynucleotides and polypeptides and their use |
| 01/02/2002 | EP1165777A2 Genes encoding human potassium channel proteins |
| 01/02/2002 | EP1165774A2 Casb619 involved in colon cancers |
| 01/02/2002 | EP1165772A1 Protein-protein complexes from s. cerevisiae and methods of using same |
| 01/02/2002 | EP1165771A2 Rt-pcr of clonal neurospheres |
| 01/02/2002 | EP1165770A2 Methods for the identification and validation of functional intracellular targets with intramers or in vivo selection |
| 01/02/2002 | EP1165763A1 Hydantoinase variants with improved properties and their use for the production of amino acids |
| 01/02/2002 | EP1165762A2 Alpha-amylase variants |
| 01/02/2002 | EP1165761A2 Methods for altering substrate specificity of phosphoinositide-dependent-protein kinase 1 (pdk1) |
| 01/02/2002 | EP1165759A1 Polypeptides having branching enzyme activity and nucleic acids encoding same |
| 01/02/2002 | EP1165758A2 Regulation of the expression of transcriptional repressor genes using nucleic acid molecules |
| 01/02/2002 | EP1165755A1 Banana and melon promoters for expression of transgenes in plants |
| 01/02/2002 | EP1165754A1 Pharmaceutical compositions comprising circulating blood cells, preferably monocytes and uses thereof |
| 01/02/2002 | EP1165753A2 Method for cultivating cancer cells from human tissue and device for preparing tissue samples |
| 01/02/2002 | EP1165749A1 Method for preparing porous, biodegradable and biocompatible, polymeric scaffolds for tissue engineering |
| 01/02/2002 | EP1165617A2 Anti-plasmodium compositions and methods of use |
| 01/02/2002 | EP1165616A1 Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases |
| 01/02/2002 | EP1165615A2 MONOCLONAL ANTIBODIES AGAINST HUMAN PROTEIN Mcm3, PROCESS FOR THEIR PRODUCTION, AND THEIR USE |
| 01/02/2002 | EP1165614A1 Antibodies against phosphomannan that are protective against candidiasis |
| 01/02/2002 | EP1165611A1 Retro-inverso prosaposin-derived peptides and use thereof |
| 01/02/2002 | EP1165609A2 Human beta-secretase enzyme, inhibitors and their compositions and uses |
| 01/02/2002 | EP1165606A1 50 human secreted proteins |
| 01/02/2002 | EP1165603A1 Human neurogenin 3-encoding nucleotide sequences |
| 01/02/2002 | EP1165602A1 49 human secreted proteins |
| 01/02/2002 | EP1165593A1 ANTISENSE MODULATION OF p38 MITOGEN ACTIVATED PROTEIN KINASE EXPRESSION |
| 01/02/2002 | EP1165592A1 INSECT p53 TUMOR SUPPRESSOR GENES AND PROTEINS |
| 01/02/2002 | EP1165591A1 47 human secreted proteins |
| 01/02/2002 | EP1165590A1 49 human secreted proteins |
| 01/02/2002 | EP1165587A1 50 human secreted proteins |
| 01/02/2002 | EP1165586A1 TCL-1b GENE AND PROTEIN AND RELATED METHODS AND COMPOSITIONS |
| 01/02/2002 | EP1165573A1 Compounds selectively inhibiting gamma 9 delta 2 t lymphocytes |
| 01/02/2002 | EP1165490A1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof |
| 01/02/2002 | EP1165143A2 Method for expressing proteins |
| 01/02/2002 | EP1165113A2 USE OF ErbB RECEPTOR LIGANDS IN TREATING DIABETES |
| 01/02/2002 | EP1165100A2 Methods of treating schizophrenia |
| 01/02/2002 | EP1165096A2 Use of cytidine derivatives for the treatment of leukaemia |
| 01/02/2002 | EP1073448B1 Fertility improving composition and application thereof |
| 01/02/2002 | EP0877796A4 Compositions and methods for mediating cell cycle progression |
| 01/02/2002 | EP0877549A4 Methods and compositions for the reduction of xenotransplantation rejection |
| 01/02/2002 | CN1329674A A beta-peptide screeining methood |
| 01/02/2002 | CN1329670A Plants and plants cells encoding wild type COP1 gene and coil domain thereof |
| 01/02/2002 | CN1329668A Polyketide synthase enzymes and recombinant DNA constructs therefor |
| 01/02/2002 | CN1329667A Fungal transcriptional activator useful in methods for producing polyptides |
| 01/02/2002 | CN1329663A Materials and methods for modification of plant lignin content |
| 01/02/2002 | CN1329619A Hypersensitive response elicitor fragments which are active but do not elicit hypersensitive response |
| 01/02/2002 | CN1329509A Adeno-associated vectors for expression of factor VIII target cells |
| 01/01/2002 | US6335321 Non-steroidal anti-inflammatory agent therapy for epithelial cell cancer |
| 01/01/2002 | US6335196 13C,15N ,2H labeled proteins for NMR structure determinations and their preparation |
| 01/01/2002 | US6335195 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation |
| 01/01/2002 | US6335193 Isolated colonocytes |
| 01/01/2002 | US6335190 Method for cloning and producing the BsmI restriction endonuclease in E. coli |
| 01/01/2002 | US6335180 Nucleic acid sequences encoding capsaicin receptor and uses thereof |
| 01/01/2002 | US6335179 Directed evolution of thermophilic enzymes |
| 01/01/2002 | US6335161 Release of intracellular material and the production therefrom of single stranded nucleic acid |
| 01/01/2002 | US6335156 Screening for anticarcinogenic/antitumor agents; incubate cells with antitumor agent, monitor cells for expression of reporter molecules |
| 01/01/2002 | US6335018 Protection against bacterial pathogens(otitis media), induction of antibodies |
| 01/01/2002 | US6335016 Chicken embryo lethal orphan (CELO) virus |
| 01/01/2002 | US6335011 Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions to treat lysosomal storage disease |
| 01/01/2002 | US6334968 Forming polysaccharide gel(from alginates solution) freezing, adding cross-linker(strontium chloride, calcium gluconate, calcium chloride);biodegradation, mechanical properties; time release agents |
| 01/01/2002 | CA2020817C Introns and exons of the cystic fibrosis gene and mutations at various positions of the gene |
| 01/01/2002 | CA1341331C Viral vector and recombinant dna coding for one or more structural protein (ha, f and/or np) of a morbillivirus, infected cell culture, resulting proteins, vaccine and antibodies |
| 12/27/2001 | WO2001098542A2 Universal collection medium |
| 12/27/2001 | WO2001098536A2 METHOD FOR ACTIVATING PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR-$g(g) |
| 12/27/2001 | WO2001098517A2 Cost effective media for large scale insect cell culture |
| 12/27/2001 | WO2001098513A2 Methods and means for the complementation of viral protein expression in stable cell lines |
| 12/27/2001 | WO2001098511A1 Tumour-cell specific gene expression and its use in cancer therapy |
| 12/27/2001 | WO2001098510A2 Dna encoding a plant lipase, transgenic plants and a method for controlling senescence in plants |
| 12/27/2001 | WO2001098509A2 Grain processing method and transgenic plants useful therein |
| 12/27/2001 | WO2001098508A2 Transgenic mice containing targeted gene disruptions |
| 12/27/2001 | WO2001098506A2 Methods and means for regulation of gene expression |
| 12/27/2001 | WO2001098499A1 Antigenic polypeptides |
| 12/27/2001 | WO2001098497A1 Secreted epithelial colon stromal-1 polypeptides, nucleic acids encoding the same and uses thereof |
| 12/27/2001 | WO2001098492A1 Novel transcription factor having zinc finger domain |
| 12/27/2001 | WO2001098491A2 Osteolevin gene polymorphisms |
| 12/27/2001 | WO2001098490A1 A g-protein coupled receptor |
| 12/27/2001 | WO2001098489A1 Nucleotide and amino acid sequences of a cellular inhibitor of the dna replication in the epstein-barr herpes virus |
| 12/27/2001 | WO2001098486A1 Mutation associated with epilepsy |
| 12/27/2001 | WO2001098485A1 Nucleic acid sequences and methods for the modification of plant gene expression |
| 12/27/2001 | WO2001098481A2 Renal regulatory elements and methods of use thereof |
| 12/27/2001 | WO2001098478A2 Clk-2, cex-7 and coq-4 genes, and uses thereof |
| 12/27/2001 | WO2001098471A2 Human phosphodiesterases |
| 12/27/2001 | WO2001098468A2 Proteases |
| 12/27/2001 | WO2001098464A2 Continuous adherent melanocyte cell line |
| 12/27/2001 | WO2001098463A1 Method of controlling differentiation of embryonic stem (es) cells by culturing es cells in the presence of bmp-2 pathway antagonists |
| 12/27/2001 | WO2001098461A1 Micro-organisms active in the digestive environment |
| 12/27/2001 | WO2001098366A2 Enterokinase cleavage sequences and their use |
| 12/27/2001 | WO2001098361A2 Agonist anti-trk-c monoclonal antibodies |
| 12/27/2001 | WO2001098360A2 Gp354 nucleic acids and polypeptides |
| 12/27/2001 | WO2001098358A2 Compositions for identification and isolation of stem cells |